CORBUS PHARMACEUTICALS HOLDI (CRBP) Stock Analyst Earnings Estimates
NASDAQ:CRBP - Nasdaq - US21833P3010 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 36.14M 649.79% | 3.94M -89.10% | 880K -77.66% | -100.00% | 1.457M | 5.391M 270.01% | 4.31M -20.05% | 33.317M 673.02% | 129.39M 288.36% | 359.06M 177.50% | 599.18M 66.87% | 825.6M 37.79% | |||
| EBITDA YoY % growth | -76.36M -35.73% | -121.69M -59.36% | -54.99M 54.81% | N/A 38.03% | N/A -30.39% | N/A | N/A | N/A | -89.658M | -93.228M -3.98% | -100.674M -7.99% | -88.842M 11.75% | 3.672M 104.13% | 110.16M 2,900.00% | |
| EBIT YoY % growth | -77.1M -35.86% | -122.81M -59.29% | -55.99M 54.41% | -39.39M 37.77% | -45.978M -29.38% | -52.043M -15.45% | -67.89M -30.45% | -87.908M -29.49% | -141.616M -61.10% | -170.308M -20.26% | -173.202M -1.70% | -21.403M 87.64% | 138.7M 748.05% | 295.19M 112.83% | |
| Operating Margin | -213.34% | -3,117.01% | -6,362.50% | N/A | N/A | N/A | -4,659.54% | -1,630.64% | -3,285.75% | -511.17% | -133.86% | -5.96% | 23.15% | 35.75% | |
| EPS YoY % growth | -1.13 -15.31% | -1.47 -30.09% | -7.64 -419.73% | -9.64 -36.26% | -11.22 2.50% | -4.30 57.65% | -5.84 -35.88% | -5.70 2.43% | -7.14 -25.36% | -7.38 -3.37% | -7.05 4.50% | -0.59 91.63% | 5.54 1,039.46% | 12.97 133.86% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.28 29.03% | -1.45 -75.12% | -1.51 -68.30% | -1.60 -39.40% | -1.70 -32.61% | -1.34 8.07% | -1.46 3.43% | -1.60 0.20% | -1.76 -3.29% |
| Revenue Q2Q % growth | |||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.761M -56.00% | -16.694M -73.48% | -17.306M -44.47% | -18.156M -52.46% | -19.04M -20.80% | -22.032M -31.98% | -23.766M -37.33% | -25.704M -41.57% | -27.846M -46.25% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.15 43.90% | -0.97 | -0.18 | -18.43% |
| Q2 2024 Q2Q % growth | -0.90 56.10% | -1.21 | 0.31 | 25.73% |
| Q1 2024 Q2Q % growth | -0.83 80.42% | -1.11 | 0.28 | 25.35% |
| Q4 2023 Q2Q % growth | -1.81 30.65% | -2.41 | 0.60 | 24.81% |
| Q3 2023 Q2Q % growth | -2.05 2.38% | -2.10 | 0.05 | 2.44% |
| Q2 2023 Q2Q % growth | -2.05 37.88% | -3.16 | 1.11 | 35.17% |
| Q1 2023 Q2Q % growth | -4.24 -76.67% | -4.17 | -0.07 | -1.63% |
| Q4 2022 Q2Q % growth | -2.61 -8.75% | -2.14 | -0.47 | -21.85% |
| Q3 2022 Q2Q % growth | -2.10 -250.00% | -1.68 | -0.42 | -24.78% |
| Q2 2022 Q2Q % growth | -3.30 26.67% | -1.84 | -1.46 | -79.74% |
| Q1 2022 Q2Q % growth | -2.40 -1,614.29% | -2.60 | 0.20 | 7.73% |
| Q4 2021 Q2Q % growth | -2.40 -2,300.00% | -3.44 | 1.04 | 30.28% |
| Q3 2021 Q2Q % growth | -0.60 -42.86% | -3.52 | 2.92 | 82.95% |
| Q2 2021 Q2Q % growth | -4.50 -765.38% | -3.61 | -0.89 | -24.63% |
| Q1 2021 Q2Q % growth | -0.14 67.44% | -0.15 | 0.01 | 8.50% |
| Q4 2020 Q2Q % growth | -0.10 75.61% | -0.26 | 0.16 | 61.10% |
| Q3 2020 Q2Q % growth | -0.42 -31.25% | -0.43 | 0.01 | 1.96% |
| Q2 2020 Q2Q % growth | -0.52 -1,833.33% | -0.39 | -0.13 | -31.68% |
| Q1 2020 Q2Q % growth | -0.43 | -0.41 | -0.02 | -4.95% |
| Q4 2019 Q2Q % growth | -0.41 | -0.37 | -0.04 | -12.28% |
| Q3 2019 Q2Q % growth | -0.32 | -0.39 | 0.07 | 17.87% |
| Q2 2019 Q2Q % growth | 0.03 | -0.36 | 0.39 | 108.26% |
| Q1 2019 Q2Q % growth | -0.43 | -0.28 | -0.15 | -54.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 153K | -153K | -100.00% |
| Q4 2021 Q2Q % growth | -100.00% | 354.45K | -354.45K | -100.00% |
| Q3 2021 Q2Q % growth | 100K -91.87% | 665.04K | -565.04K | -84.96% |
| Q2 2021 Q2Q % growth | 140K -51.72% | 892.5K | -752.5K | -84.31% |
| Q1 2021 Q2Q % growth | 650K -63.07% | 983.79K | -333.79K | -33.93% |
| Q4 2020 Q2Q % growth | 660K -74.32% | 1.52M | -860K | -56.58% |
| Q3 2020 Q2Q % growth | 1.23M -52.51% | 2.749M | -1.519M | -55.26% |
| Q2 2020 Q2Q % growth | 290K -99.00% | 3.052M | -2.762M | -90.50% |
| Q1 2020 Q2Q % growth | 1.76M -6.88% | 2.46M | -700K | -28.46% |
| Q4 2019 Q2Q % growth | 2.57M | 3.759M | -1.189M | -31.63% |
| Q3 2019 Q2Q % growth | 2.59M | 1.875M | 715K | 38.13% |
| Q2 2019 Q2Q % growth | 29.09M | 3.153M | 25.937M | 822.61% |
| Q1 2019 Q2Q % growth | 1.89M | 1.562M | 328K | 21.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0.14% | -13.56% |
| Revenue | N/A | N/A | N/A | N/A |